Regulation of body growth

Current Opinion in Pediatrics

Volumn 27, Issue 4, 2015, Pages 502-510

  Lui, Julian C ^a   Garrison, Presley ^a   Baron, Jeffrey ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

endocrine; genetic program; growth plate; Keywords body size; proliferation

Indexed keywords

DNA METHYLTRANSFERASE 3A; ESTROGEN; GROWTH HORMONE; SOMATOMEDIN C;

AGE; ASSOCIATION; BODY GROWTH; BODY HEIGHT; CHROMOSOME DUPLICATION; CHROMOSOME XQ; DROSOPHILA; EPIGENETICS; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GROWTH ACCELERATION; GROWTH DISORDER; GROWTH PLATE; GROWTH REGULATION; HIPPO SIGNALING PATHWAY; HUMAN; HUMAN GENOME; MAMMAL; META ANALYSIS (TOPIC); NEUROENDOCRINE SYSTEM; NONHUMAN; NUTRITION; ORGAN SIZE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; CHILD; CHILD NUTRITION; GENE EXPRESSION PROFILING; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HIPPOCAMPUS; INFANT; METABOLISM; MUTATION; NEWBORN; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PRESCHOOL CHILD; QUANTITATIVE TRAIT LOCUS;

BODY HEIGHT; CHILD; CHILD NUTRITIONAL PHYSIOLOGICAL PHENOMENA; CHILD, PRESCHOOL; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; GROWTH DISORDERS; GROWTH PLATE; HIPPOCAMPUS; HUMANS; INFANT; INFANT, NEWBORN; MUTATION; PHENOTYPE; QUANTITATIVE TRAIT LOCI; SIGNAL TRANSDUCTION;

EID: 84945570486     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000235     Document Type: Review

References (87)

1. Gomer RH. Not being the wrong size. Nat Rev Mol Cell Biol 2001; 2: 48-54
2. Reiter EO, Rosenfeld RG. Normal and aberrant growth. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, editors. Williams textbook of endocrinology, 10th ed. Philadelphia: Saunders; 2003. pp. 1003-1114
3. Bogin B. Evolutionary perspective on human growth. Annu Rev Anthropol 1999; 28: 109-153
4. Abad V, Meyers JL, Weise M, et al. The role of the resting zone in growth plate chondrogenesis. Endocrinology 2002; 143: 1851-1857
5. Rosenfeld RG, Belgorosky A, Camacho-Hubner C, et al. Defects in growth hormone receptor signaling. Trends Endocrinol Metab 2007; 18: 134-141
6. Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P. Genetic mutations in sporadic pituitary adenomas -what to screen for?. Nat Rev Endocrinol 2015; 11: 43-54
7. Trivellin G, Daly AF, Faucz FR, et al. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 2014; 371: 2363-2374
8. Garcia-Aragon J, Lobie PE, Muscat GE, et al. Prenatal expression of the growth hormone (GH) receptor/binding protein in the rat: a role for GH in embryonic and fetal development?. Development 1992; 114: 869-876
9. Abuzzahab MJ, Schneider A, Goddard A, et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003; 349: 2211-2222
10. Fang P, Hi CY, Derr MA, et al. Severe short stature caused by novel compound heterozygous mutations of the insulin-like growth factor 1 receptor (IGF1R). J Clin Endocrinol Metab 2012; 97: E243-E247
11. Giudice LC, De ZF, Gargosky SE, et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995; 80: 1548-1555
12. Czeszynska MB, Janus D, Pankiewicz E, et al. 74 Gestational diabetes: cord blood insulin, IGF-I and IGF-II levels in relation to anthropometric parameters of neonates born as AGA or LGA. Pediatr Res 2005; 58: 367
13. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993; 75: 73-82
14. Zachmann M, Prader A, Sobel EH, et al. Pubertal growth in patients with androgen insensitivity: indirect evidence for the importance of estrogens in pubertal growth of girls. J Pediatr 1986; 108 (5 Pt 1): 694-697
15. Grumbach MM. Estrogen, bone, growth and sex: a sea change in conventional wisdom. J Pediatr Endocrinol Metab 2000; 13 (Suppl 6): 1439-1455
16. Leung KC, Johannsson G, Leong GM, Ho KK. Estrogen regulation of growth hormone action. Endocr Rev 2004; 25: 693-721
17. Nilsson O, Chrysis D, Pajulo O, et al. Localization of estrogen receptors- A and-b and androgen receptor in the human growth plate at different pubertal stages. J Endocrinol 2003; 177: 319-326
18. Blanchard O, Tsagris L, Rappaport R, et al. Age-dependent responsiveness of rabbit and human cartilage cells to sex steroids in vitro. J Steroid Biochem Mol Biol 1991; 40 (4-6): 711-716
19. Weise M, De-Levi S, Barnes KM, et al. Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci U S A 2001; 98: 6871-6876
20. Sigurjonsdottir TJ, Hayles AB. Precocious puberty: a report of 96 cases. Am J Dis Child 1968; 115: 309-321
21. Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331: 1056-1061
22. Smith EP, Specker B, Bachrach BE, et al. Impact on bone of an estrogen receptor- A gene loss of function mutation. J Clin Endocrinol Metab 2008; 93: 3088-3096
23. Quaynor SD, Stradtman EW Jr, Kim HG, et al. Delayed puberty and estrogen resistance in a woman with estrogen receptor- A variant. N Engl J Med 2013; 369: 164-171
24. Hero M, Wickman S, Dunkel L. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty. Clin Endocrinol (Oxf) 2006; 64: 510-513
25. Hero M, Norjavaara E, Dunkel L. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. J Clin Endocrinol Metab 2005; 90: 6396-6402
26. Weise M, Flor A, Barnes KM, et al. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty. J Clin Endocrinol Metab 2004; 89: 103-107
27. Nilsson O, Weise M, Landman EB, et al. Evidence that estrogen hastens epiphyseal fusion and cessation of longitudinal bone growth by irreversibly depleting the number of resting zone progenitor cells in female rabbits. Endocrinology 2014; 155: 2892-2899
28. Victora CG, Adair L, Fall C, et al. Maternal and child undernutrition: consequences for adult health and human capital. Lancet 2008; 371: 340-357
29. Black RE, Allen LH, Bhutta ZA, et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 2008; 371: 243-260
30. Jain S, Golde DW, Bailey R, Geffner ME. Insulin-like growth factor-I resistance. Endocr Rev 1998; 19: 625-646
31. Straus DS, Takemoto CD. Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver. Mol Endocrinol 1990; 4: 91-100
32. Bornfeldt KE, Arnqvist HJ, Enberg B, et al. Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol 1989; 122: 651-656
33. Thissen JP, Underwood LE, Maiter D, et al. Failure of insulin-like growth factor- I (IGF-I) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations. Endocrinology 1991; 128:885-890
34. Lawson EA, Donoho D, Miller KK, et al. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab 2009; 94: 4710-4716
35. Warner MH, Beckett GJ. Mechanisms behind the nonthyroidal illness syndrome: an update. J Endocrinol 2010; 205: 1-13
36. Chou SH, Chamberland JP, Liu X, et al. Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci U S A 2011; 108: 6585-6590
37. Potthoff MJ, Inagaki T, Satapati S, et al. FGF21 induces PGC-1a and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci U S A 2009; 106: 10853-10858
38. Inagaki T, Lin VY, Goetz R, et al. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab 2008; 8: 77-83
39. Yamamoto M, Iguchi G, Fukuoka H, et al. SIRT1 regulates adaptive response of the growth hormone-insulin-like growth factor-I axis under fasting conditions in liver. Proc Natl Acad Sci U S A 2013; 110: 14948-14953
40. Fan Y, Menon RK, Cohen P, et al. Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J Biol Chem 2009; 284: 19937-19944
41. Wu S, Grunwald T, Kharitonenkov A, et al. Increased expression of fibroblast growth factor 21 (FGF21) during chronic undernutrition causes growth hormone insensitivity in chondrocytes by inducing leptin receptor overlapping transcript (LEPROT) and leptin receptor overlapping transcript-like 1 (LEPROTL1) expression. J Biol Chem 2013; 288: 27375-27383
42. Guasti L, Silvennoinen S, Bulstrode NW, et al. Elevated FGF21 leads to attenuated postnatal linear growth in preterm infants through GHresistance in chondrocytes. J Clin Endocrinol Metab 2014; 99: E2198-E2206
43. Kubicky RA, Wu S, Kharitonenkov A, De LF. Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice. Endocrinology 2012; 153: 2287-2295
44. Tapon N, Harvey KF, Bell DW, et al. Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 2002; 110: 467-478
45. Wu S, Huang J, Dong J, Pan D. Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 2003; 114: 445-456
46. Huang J, Wu S, Barrera J, et al. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005; 122: 421-434
47. Dong J, Feldmann G, Huang J, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007; 130: 1120-1133
48. Plouffe SW, Hong AW, Guan KL. Disease implications of the Hippo/YAP pathway. Trends Mol Med 2015; 21: 212-222
49. Jia J, Zhang W, Wang B, et al. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev 2003; 17: 2514-2519
50. Tao W, Zhang S, Turenchalk GS, et al. Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet 1999; 21: 177-181
51. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993; 75: 826
52. Steinhardt AA, Gayyed MF, Klein AP, et al. Expression of Yes-associated protein in common solid tumors. Hum Pathol 2008; 39: 1582-1589
53. Wang X, Su L, Ou Q. Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer. Eur J Cancer 2012; 48: 1227-1234
54. Wang L, Shi S, Guo Z, et al. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS One 2013; 8: e65539
55. Wang J, Ma L, Weng W, et al. Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer. Hepatology 2013; 58: 1011-1020
56. Song H, Mak KK, Topol L, et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci U S A 2010; 107: 1431-1436
57. Heallen T, Zhang M, Wang J, et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011; 332: 458-461
58. Zhao R, Fallon TR, Saladi SV, et al. YAP tunes airway epithelial size and architecture by regulating the identity, maintenance, and self-renewal of stem cells. Dev Cell 2014; 30: 151-165
59. Mahoney JE, Mori M, Szymaniak AD, et al. The hippo pathway effector YAP controls patterning and differentiation of airway epithelial progenitors. Dev Cell 2014; 30: 137-150
60. Lui JC, Finkielstain GP, Barnes KM, Baron J. An imprinted gene network that controls mammalian somatic growth is down-regulated during postnatal growth deceleration in multiple organs. Am J Physiol Regul Integr Comp Physiol 2008; 295: R189-R196
61. Finkielstain GP, Forcinito P, Lui JC, et al. An extensive genetic program occurring during postnatal growth in multiple tissues. Endocrinology 2009; 150: 1791-1800
62. Delaney A, Padmanabhan V, Rezvani G, et al. Evolutionary conservation and modulation of a juvenile growth-regulating genetic program. J Mol Endocrinol 2014; 52: 269-277
63. Lui JC, Forcinito P, Chang M, et al. Coordinated postnatal down-regulation of multiple growth-promoting genes: evidence for a genetic program limiting organ growth. FASEB J 2010; 24: 3083-3092
64. Rezvani G, Lui JC, Barnes KM, Baron J. A set of imprinted genes required for normal body growth also promotes growth of rhabdomyosarcoma cells. Pediatr Res 2012; 71: 32-38
65. Chase A, Cross NC. Aberrations of EZH2 in cancer. Clin Cancer Res 2011; 17: 2613-2618
66. Kishida S, Mu P, Miyakawa S, et al. Midkine promotes neuroblastoma through Notch2 signaling. Cancer Res 2013; 73: 1318-1327
67. Lui JC, Baron J. Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3. Proc Natl Acad Sci U S A 2013; 110: 6181-6186
68. Lui JC, Baron J. Mechanisms limiting body growth in mammals. Endocr Rev 2011; 32: 422-440
69. Nilsson O, Marino R, De LF, et al. Endocrine regulation of the growth plate. Horm Res 2005; 64: 157-165
70. Hao Y, Liu X, Lu X, et al. Genome-wide association study in Han Chinese identifies three novel loci for human height. Hum Genet 2013; 132: 681-689
71. Okada Y, Kamatani Y, Takahashi A, et al. A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci. Hum Mol Genet 2010; 19: 2303-2312
72. Lei SF, Tan LJ, Liu XG, et al. Genome-wide association study identifies two novel loci containing FLNB and SBF2 genes underlying stature variation. Hum Mol Genet 2009; 18: 1661-1669
73. Lettre G, Jackson AU, Gieger C, et al. Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet 2008; 40: 584-591
74. Sanna S, Jackson AU, Nagaraja R, et al. Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet 2008; 40: 198-203
75. Weedon MN, Lettre G, Freathy RM, et al. A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat Genet 2007; 39: 1245-1250
76. Gudbjartsson DF, Walters GB, Thorleifsson G, et al. Many sequence variants affecting diversity of adult human height. Nat Genet 2008; 40: 609-615
77. Lango AH, Estrada K, Lettre G, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010; 467: 832-838
78. Lui JC, Nilsson O, Chan Y, et al. Synthesizing genome-wide association studies and expression microarray reveals novel genes that act in the human growth plate to modulate height. Hum Mol Genet 2012; 21: 5193-5201
79. Wood AR, Esko T, Yang J, et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet 2014; 46: 1173-1186
80. Tompson SW, Merriman B, Funari VA, et al. A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan. Am J Hum Genet 2009; 84: 72-79
81. Gleghorn L, Ramesar R, Beighton P, Wallis G. A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. Am J Hum Genet 2005; 77: 484-490
82. Nilsson O, Guo MH, Dunbar N, et al. Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations. J Clin Endocrinol Metab 2014; 99: E1510-E1518
83. Tatton-Brown K, Hanks S, Ruark E, et al. Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height. Oncotarget 2011; 2: 1127-1133
84. Gibson WT, Hood RL, Zhan SH, et al. Mutations in EZH2 cause Weaver syndrome. Am J Hum Genet 2012; 90: 110-118
85. Kurotaki N, Imaizumi K, Harada N, et al. Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet 2002; 30: 365-366
86. Luscan A, Laurendeau I, Malan V, et al. Mutations in SETD2 cause a novel overgrowth condition. J Med Genet 2014; 51: 512-517
87. Tatton-Brown K, Seal S, Ruark E, et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat Genet 2014; 46: 385-388